Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05063812 · ClinicalTrials.gov registry record
Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
A clinical trial of Covid19 and Infectious Disease, sponsored by George Washington University.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT05063812 is a study of Covid19 and Infectious Disease that has completed, run by George Washington University. The registered enrollment target is 18 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05063812, a study of Covid19 and Infectious Disease, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The GW Medical Faculty Associates recently launched a remote monitoring program for patients diagnosed with COVID-19. Patients are provided with a home pulse oximeter and thermometer. Participants complete daily surveys about their symptoms and vital signs and are escalated to receive phone calls and video visits if responses are abnormal. Investigators would like to complete a study of the program to understand: 1. Operational parameters of program performance, such as how many patients were enrolled and how many patients completed monitoring 2. Clinical course of patients, including their reported symptoms over time and clinical endpoints such as hospitalization or ICU admission 3. Patient satisfaction with program
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
District of Columbia
- The George Washington University, Department of Emergency Medicine - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05063812
The ClinicalTrials.gov registry entry for NCT05063812 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (99% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT05063812 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05063812 about?
NCT05063812 is a clinical study titled "Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19". The GW Medical Faculty Associates recently launched a remote monitoring program for patients diagnosed with COVID-19. Patients are provided with a home pulse oximeter and thermometer. Participants complete daily surveys about their symptoms and vital signs and are escalated to receive phone calls an...
What is the current status of trial NCT05063812?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2020-09-21. Estimated completion is 2023-12-31.
What conditions does trial NCT05063812 study?
This clinical trial studies the following conditions: Covid19, Infectious Disease, SARS-CoV Infection.
What interventions are being tested in trial NCT05063812?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT05063812?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05063812 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.